Italia markets closed

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
8,630,00 (0,00%)
Alla chiusura: 11:27AM EST

Teva Pharmaceutical Industries Limited

124 Dvora Hanevi’a Street
Tel Aviv 6944020
Israel
972 3 914 8213
https://www.tevapharm.com

Settore/iHealthcare
SettoreDrug Manufacturers—Specialty & Generic
Impiegati a tempo pieno37.100

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kare SchultzPres, CEO & Director5,72MN/D1961
Mr. Eliyahu Sharon KalifExec. VP & CFO1,77MN/D1973
Mr. Eric DrapeExec. VP of Global Operations2,05MN/D1962
Dr. Hafrun FridriksdottirExec. VP of Global R&D2,29MN/D1962
Mr. Amir WeissSr. VP & Chief Accounting OfficerN/DN/D1977
Mr. Kevin C. MannixSr. VP of Investor RelationsN/DN/DN/D
Mr. David M. StarkExec. VP & Chief Legal OfficerN/DN/D1969
Ms. Lori QueisserSr. VP & Global Compliance OfficerN/DN/DN/D
Ms. Galia InbarExec. VP, Chief HR Officer and Head of Global Communications, Brand & ESGN/DN/DN/D
Mr. Eli ShaniExec. VP of Global Marketing & PortfolioN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell S.A. to develop mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Governance aziendale

L'ISS Governance QualityScore di Teva Pharmaceutical Industries Limited al 26 settembre 2021 è 4. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 4; diritti degli azionisti: 3; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.